| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $26.6M | — |
| R&D Expense | $173.4M | +31.3% |
| SG&A Expense | $57.0M | +54.4% |
| Interest Expense | $3.3M | +162.7% |
| Income Tax | $0 | — |
| Net Income | -$204.2M | -20.1% |
| EPS (Basic) | -$2.18 | +9.5% |
| EPS (Diluted) | -$2.18 | +9.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $128.9M | -27.6% |
| Accounts Receivable | $30.0M | — |
| Current Assets | $319.2M | +69.0% |
| Total Assets | $334.3M | +62.2% |
| Current Liabilities | $91.5M | +92.6% |
| Long-term Debt | $24.9M | +1.2% |
| Total Liabilities | $242.3M | +187.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$49.4M | +64.7% |
| Capital Expenditures | $2.2M | +239.0% |
| Investing Cash Flow | -$152.7M | — |
| Financing Cash Flow | $153.0M | +140.4% |
| Free Cash Flow | -$51.6M | +63.3% |
| Stockholders' Equity |
| $92.1M |
| -24.4% |